Career history of Jan van Tornout
Former positions of Jan van Tornout
| Companies | Position | Start | End |
|---|---|---|---|
| TYME TECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 2021-03-31 | 2022-04-30 |
Training of Jan van Tornout
| University of Southern California | Graduate Degree |
| Katholieke Universiteit Leuven Law School | Doctorate Degree |
| Facultés Universitaires Notre-Dame de la Paix | Undergraduate Degree |
Statistics
International
| United States | 3 |
| Belgium | 3 |
Operational
| Graduate Degree | 2 |
| Doctorate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
- Stock Market
- Insiders
- Jan van Tornout
- Experience
